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Inhibitory and resistance-modifying potential of plant-based alkaloids against 
methicillin-resistant staphylococcus aureus (MRSA) 
 
ABSTRACT 
Increased prevalence of methicillin-resistant Staphylococcus aureus (MRSA) has become a 
major threat to the health sector worldwide due to their virulence, limited therapeutic options 
and their distribution in both hospital and community settings. Discovery and development of 
new anti-MRSA agents as alternatives to the very few antibiotics left in the armamentarium 
are, thus, urgently required. Recently, an efflux mechanism in MRSA has been identified as 
one of the main contributors of resistance towards various structurally unrelated antibiotics. 
The potential of reserpine (a phytoalkaloid) as efflux pump inhibitor (EPI) against various 
microbes remains limited as the concentration needed for inhibition is toxic to humans. This 
study therefore aimed to evaluate 13 alkaloid compounds as potential inhibitory agents and/or 
potential EPIs against a panel of three MRSA isolates which not only differ in their 
susceptibility to vancomycin (amongst the last drugs available to treat serious MRSA 
infection), but also exhibited active efflux activity. Results indicated berberine's moderate 
inhibitiory activity against two MRSA isolates scoring a minimum inhibitory concentration 
(MIC) value of 125 microg/ml. Notable efflux inhibitory activity (ranging from two- to 
eightfold Ethidium Bromide MIC reduction) meanwhile was detected from quinine, piperine 
and harmaline using reserpine as the positive control. Findings from this study support the 
opinion that a vast number of potential phytocompounds with pharmacological potential 
await discovery. Therapeutic application of these compounds, however, warrants further 
investigation to ascertain their pharmacodynamics and safety aspects. 
 
